New York Health Care, Inc. (BBAL)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
New York Health Care, Inc. (BBAL) trades at $0.00 with AI Score 39/100 (Grade D). New York Health Care, Inc. provides home care services in New York, including companionship, nursing, and specialized care. Market cap: $3,354, Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for BBAL: BBAL does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BBAL against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
BBAL: 1/1 perspectives are bearish.
How is this calculated? →New York Health Care, Inc. (BBAL) Healthcare & Pipeline Overview
New York Health Care, Inc., established in 1983, operates as a home care services agency in New York, offering a range of services from companionship to specialized dementia care, positioning itself within the growing but competitive healthcare facilities sector with a focus on in-home assistance.
What Is the Investment Thesis for BBAL?
New York Health Care, Inc. presents a focused play on the New York home healthcare market. The company's long-standing presence since 1983 and comprehensive service offerings, including specialized dementia care, position it to capitalize on the aging population demographic. However, the company's negative profit margin of -2.4% and lack of dividend pose concerns. Growth catalysts include expansion of service offerings and strategic partnerships within the New York region. Key risks include competition from larger national players and potential regulatory changes impacting the home healthcare industry. Investors should closely monitor the company's ability to improve profitability and manage operational costs.
Based on FMP financials and quantitative analysis
BBAL Key Highlights
- New York Health Care, Inc. operates primarily in the New York home care services market.
- The company offers a range of services including companionship, homemaking, skilled nursing, and specialized dementia care.
- The company's profit margin is -2.4%, indicating a need for improved profitability.
- The company's gross margin is 17.5%.
- The company has a beta of -10.51, suggesting an inverse correlation to market movements, but this may be an outlier.
Who Are BBAL's Competitors?
BBAL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| SLHGP Skylight Health Group Inc. | $12.00 | -5.88% | 61 | |
| NWKHY Netcare Limited | $7.17 | +0.00% | $843.64M | 50 |
| AONC American Oncology Network, Inc. | $10.00 | +0.00% | $292.48M | 50 |
| DCGO DocGo Inc. | $0.59 | +5.81% | $58.07M | 51 |
| JYNT The Joint Corp. | $9.16 | +2.10% | $130.55M | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BBAL's Key Strengths?
- Established presence in the New York market.
- Comprehensive range of home care services.
- Specialized dementia and Alzheimer's care expertise.
- Experienced management team.
What Are BBAL's Weaknesses?
- Negative profit margin.
- Limited geographic diversification.
- Reliance on a single market (New York).
- Lack of dividend payments.
What Could Drive BBAL Stock Higher?
- Potential partnerships with local hospitals and healthcare providers to expand referral network.
- Increasing demand for home care services due to the aging population.
- Expansion of specialized dementia and Alzheimer's care services to capture a larger market share.
What Are the Key Risks for BBAL?
- Financial-distress signal — its Altman Z-Score of -1.02 sits in the distress zone (elevated bankruptcy risk).
- Intense competition from larger national home care providers.
- Regulatory changes impacting reimbursement rates for home care services.
- Negative profit margin affecting financial stability.
- Economic downturn reducing demand for non-essential home care services.
What Are the Growth Opportunities for BBAL?
- Expansion of Dementia and Alzheimer's Care Services: The increasing prevalence of dementia and Alzheimer's disease presents a significant growth opportunity for New York Health Care, Inc. By expanding its specialized care programs and training its staff in advanced dementia care techniques, the company can attract a larger share of this growing market segment. The Alzheimer's Association estimates that the number of Americans living with Alzheimer's will reach 13.8 million by 2050, indicating a substantial long-term demand for specialized care services.
- Strategic Partnerships with Hospitals and Healthcare Providers: Collaborating with local hospitals and healthcare providers can create a referral network and drive patient volume for New York Health Care, Inc. By partnering with these institutions, the company can gain access to a steady stream of patients requiring post-acute care and home-based services. This strategy can also enhance the company's reputation and credibility within the healthcare community, leading to increased trust and brand recognition.
- Technology Integration for Enhanced Service Delivery: Implementing technology solutions, such as remote monitoring devices and telehealth platforms, can improve the efficiency and effectiveness of New York Health Care, Inc.'s services. Remote monitoring allows caregivers to track patients' vital signs and detect potential health issues early on, while telehealth enables virtual consultations and remote support. These technologies can enhance patient outcomes, reduce hospital readmissions, and improve caregiver productivity.
- Geographic Expansion within New York State: While New York Health Care, Inc. currently focuses on the Valley Stream area, expanding its service area to other regions within New York State can unlock new growth opportunities. By targeting areas with a high concentration of elderly residents and limited access to home healthcare services, the company can increase its market share and revenue. This expansion strategy should be carefully planned and executed, with a focus on building a strong local presence and establishing relationships with key stakeholders.
- Development of Value-Based Care Programs: As the healthcare industry shifts towards value-based care models, New York Health Care, Inc. can develop programs that focus on improving patient outcomes and reducing healthcare costs. By demonstrating its ability to deliver high-quality care at a lower cost, the company can attract contracts with managed care organizations and government payers. This strategy requires a focus on data analytics, care coordination, and patient engagement to achieve measurable improvements in patient health and satisfaction.
What Opportunities Does BBAL Have?
- Expansion of dementia care services.
- Strategic partnerships with hospitals and healthcare providers.
- Technology integration for enhanced service delivery.
- Geographic expansion within New York State.
What Threats Does BBAL Face?
- Intense competition from larger national players.
- Regulatory changes impacting the home healthcare industry.
- Reimbursement pressures from managed care organizations.
- Economic downturn affecting demand for home care services.
What Are BBAL's Competitive Advantages?
- Established presence in the New York home care services market since 1983.
- Comprehensive range of services, including specialized dementia care.
- Local expertise and knowledge of the New York healthcare landscape.
What Does BBAL Do?
Founded in 1983 and based in Valley Stream, New York, New York Health Care, Inc. has established itself as a provider of in-home care services. The company's core business revolves around offering a suite of home care solutions designed to meet the diverse needs of its clients. These services include companionship, homemaking, and skilled nursing care. New York Health Care, Inc. also provides specialized care for individuals with conditions such as dementia and Alzheimer's disease, addressing a critical and growing need within the aging population. In addition to its care services, the company also offers insurance services, diversifying its revenue streams and providing a more comprehensive offering to its client base. The company employs 1460 individuals. New York Health Care, Inc. operates primarily within New York, focusing its resources and expertise on serving the local community. While the company has a long history and established presence, it operates in a competitive landscape with both national and regional players.
What Products and Services Does BBAL Offer?
- Provides companionship services to individuals in their homes.
- Offers homemaker and housekeeper staff for assistance with daily tasks.
- Employs professional and practical nurses for skilled nursing care.
- Provides home health aides for personal care and support.
- Offers care givers for various levels of assistance.
- Specializes in geriatric care for elderly individuals.
- Provides dementia and Alzheimer's care services.
How Does BBAL Make Money?
- Generates revenue by providing home care services to individuals in New York.
- Charges fees for companionship, homemaking, nursing, and specialized care services.
- Offers insurance services as an additional revenue stream.
What Industry Does BBAL Operate In?
New York Health Care, Inc. operates within the medical care facilities industry, a segment driven by the aging population and increasing demand for home-based healthcare services. The industry is characterized by a mix of large national chains and smaller regional players. Competition is intense, with companies vying for market share through service differentiation and geographic expansion. Market trends include a growing emphasis on personalized care and technology integration to improve efficiency and patient outcomes. The industry is subject to regulatory oversight and reimbursement policies, which can significantly impact profitability.
Who Are BBAL's Key Customers?
- Elderly individuals requiring assistance with daily living activities.
- Individuals with disabilities or chronic illnesses needing home care support.
- Families seeking care for loved ones with dementia or Alzheimer's disease.
- Individuals requiring post-operative or rehabilitative care at home.
How New York Health Care, Inc. Is Valued
New York Health Care, Inc. carries a market capitalization of 3K, placing it in the micro-cap category. Relative to its peer group, BBAL's quantitative score of 39/100 is below the peer average of 60/100.
Company Profile
New York Health Care, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Valley Stream, US. The company is led by CEO Murray Englard. BBAL has traded publicly since 1996.
ROE 45%Key Financial Metrics
Return on equity for New York Health Care, Inc. stands at 45.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -8.5%, showing how much profit it generates from its asset base. A current ratio of 0.71 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 5/9Financial Health
New York Health Care, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -1.02 places it in the distress zone, a signal of elevated financial risk.
BBAL Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Established presence in the New York market.
- Comprehensive range of home care services.
- Specialized dementia and Alzheimer's care expertise.
- Experienced management team.
Bear Case
- Negative profit margin.
- Limited geographic diversification.
- Reliance on a single market (New York).
- Lack of dividend payments.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
BBAL Latest News
No recent news available for BBAL.
BBAL Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BBAL.
Price Targets
Wall Street price target analysis for BBAL.
BBAL MoonshotScore
What does this score mean?
The MoonshotScore rates BBAL's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Murray Englard
CEO
Murray Englard is the CEO of New York Health Care, Inc. He has been managing 1460 employees. Additional background information regarding his career history, education, and previous roles is not available in the provided data.
Track Record: Specific achievements and strategic decisions made by Murray Englard during his tenure as CEO are not available in the provided data. Therefore, it is not possible to assess his track record or identify key company milestones under his leadership.
BBAL OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that New York Health Care, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB, or major exchanges like NYSE or NASDAQ. Companies in this tier often have limited operating history, minimal assets, or are undergoing financial distress. Investing in OTC Other stocks carries significant risks due to the lack of regulatory oversight and transparency compared to listed exchanges. Information availability may be limited, making it difficult to assess the company's financial health and prospects.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Low trading volume and liquidity.
- Higher potential for fraud and manipulation.
- Greater price volatility.
- Risk of delisting or going dark.
- Verify the company's financial statements and disclosures.
- Assess the company's management team and their experience.
- Research the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Determine the company's ownership structure and shareholder base.
- Monitor trading volume and price activity for unusual patterns.
- Consult with a qualified financial advisor.
- Longevity of operations since 1983.
- Provision of essential home care services.
- Employment of a significant number of individuals (1460).
- Physical headquarters in Valley Stream, New York.
- Focus on a specific geographic market (New York).
New York Health Care, Inc. Healthcare Stock: Key Questions Answered
What does New York Health Care, Inc. do?
New York Health Care, Inc. operates as a home care services agency, primarily serving the New York area. The company provides a range of in-home care services, including companionship, homemaking, skilled nursing, and specialized care for individuals with dementia and Alzheimer's disease. By offering these services, New York Health Care, Inc. aims to support individuals who require assistance with daily living activities, enabling them to remain in the comfort of their own homes. The company also offers insurance services.
What do analysts say about BBAL stock?
As of March 18, 2026, there is no available analyst coverage or consensus on BBAL stock. Given the company's OTC Other listing and limited financial information, it is unlikely that major brokerage firms provide research coverage. Investors should conduct their own thorough due diligence and consider the inherent risks associated with investing in OTC stocks before making any investment decisions. Key valuation metrics, such as price targets or earnings estimates, are not available.
What are the main risks for BBAL?
The main risks for New York Health Care, Inc. include intense competition from larger national home care providers, regulatory changes impacting reimbursement rates, and the company's current negative profit margin. As an OTC-listed company, BBAL also faces risks related to limited financial disclosure, low trading volume, and potential for price volatility. An economic downturn could reduce demand for non-essential home care services, further impacting the company's financial performance. Investors should carefully consider these risks before investing.
What are the key factors to evaluate for BBAL?
New York Health Care, Inc. (BBAL) holds an AI score of 39/100 (low). Not financial advice.
How frequently does BBAL data refresh on this page?
BBAL prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven BBAL's recent stock price performance?
New York Health Care, Inc. (BBAL) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established presence in the New York market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BBAL overvalued or undervalued right now?
Valuing New York Health Care, Inc. (BBAL) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying BBAL?
Before investing in New York Health Care, Inc. (BBAL), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available for comprehensive analysis.
- OTC Other status indicates higher investment risk.